/Companies

NovaGo Therapeutics

Schlieren, CH · Founded 2015 · 10 employees on LinkedIn · 1 known investors

Find your way into NovaGo Therapeutics

Sign up to see every warm intro you have to NovaGo Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NovaGo Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NovaGo Therapeutics is a biotech company developing antibody-based therapeutics to promote nerve repair and recovery following spinal cord injury. The company's candidates are designed to enhance nerve regeneration and functional recovery, with Phase 1 clinical trials expected to begin in 2024.

Investors · 1

Funding

SEC filings, press & company announcements

$30M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does NovaGo Therapeutics do?
NovaGo Therapeutics is a biotech company developing antibody-based therapeutics to promote nerve repair and recovery following spinal cord injury. The company's candidates are designed to enhance nerve regeneration and functional recovery, with Phase 1 clinical trials expected to begin in 2024.
Who are NovaGo Therapeutics's investors?
NovaGo Therapeutics's investors include Pureos Bioventures.
How much funding has NovaGo Therapeutics raised?
NovaGo Therapeutics has disclosed $30M raised across 1 round.
Where is NovaGo Therapeutics headquartered?
NovaGo Therapeutics is headquartered in Schlieren, CH.